[SYRS] YoY Quarter Result on 31-Dec-2015 [#Q4]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
30-Dec-2015
Financial Year
2015
Quarter
31-Dec-2015 [#Q4]
Profit Trend
QoQ- -26.29%
YoY- -121.49%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 5,699 508 893 0 317 0 0 -
PBT -30,130 -19,729 -18,032 -15,302 -10,965 -10,689 -3,689 41.86%
Tax 1,417 0 0 -390 0 0 1,137 3.73%
NP -30,130 -19,729 -18,032 -15,302 -10,965 -10,689 -4,826 35.65%
Tax Rate - - - - - - - -
Total Cost 35,829 20,237 18,925 15,302 11,282 10,689 4,826 39.62%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -528.69 -3,883.66 -2,019.26 0.00 -3,458.99 0.00 0.00 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -4.91 -4.60 -5.35 -5.81 -4.69 -5.96 -29.78 -25.92%
EPS Diluted -4.91 -4.49 -5.34 -5.81 -4.69 -5.96 -29.78 -25.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.